General Surgery makes up 45.0% of the application segment, and established institutional buyers buy the most of it. This concentration is due to structural demand that is based on operational needs, not on personal preferences.
The absorbable PGA surgical sutures market encompasses synthetic absorbable sutures manufactured from polyglycolic acid polymer in monofilament, braided, coated, and non-coated configurations for wound closure in general surgery, obstetrics, urology, cardiovascular, and orthopedic applications.
Market scope includes all commercially traded products segmented by type, application. Revenue sizing spans 2026 to 2036.
The scope excludes related but distinct product categories and products manufactured exclusively for captive internal use.
The market for absorbable pga surgical sutures is growing because core application sectors are buying more and new clinical or industrial needs are arising. Monofilament makes up 67.0% of the type segment, which shows that people prefer tried-and-true designs that work well in the main use cases.
General Surgery makes up 45.0% of the application segment, and established institutional buyers buy the most of it. This concentration is due to structural demand that is based on operational needs, not on personal preferences.
Geographic demand patterns are a result of the growth of the healthcare system and industry. China leads growth with an 8.9% CAGR, thanks to more capacity and more demand at home. Developed markets keep providing steady replacement volumes, while emerging markets help growth speed up by building new facilities and making access easier.
The absorbable pga surgical sutures market is segmented by type, application, and geographic regions. By type, the market is segmented as Monofilament, Braided, Coated, Non-coated. By application, the market is classified by General Surgery, Obstetrics and Gynecology, Urology, Cardiovascular Surgery, Orthopedic Surgery, Others.
Monofilament is projected to lead with a 67.0% share in 2026. This leadership reflects established performance credentials, broad application suitability, and competitive economics that sustain procurement preference across primary end-use categories.
General Surgery is expected to capture 45.0% in 2026. This segment generates the largest procurement volumes from established institutional and commercial buyers who maintain standardized specifications.
The absorbable pga surgical sutures market is advancing as primary application sectors expand and technology development creates new opportunities. Despite challenges including cost pressure, competitive intensity, and regulatory complexity, growth opportunities are emerging from innovation, sustainability, and geographic expansion.
Investment growth in key sectors affects demand. General Surgery alone makes up 45.0% of demand, which means that most of the money comes from this area.
The costs of inputs and the rules that must be followed make things more complicated. Companies that have strong compliance systems stay ahead of the competition.
Advanced materials, better designs, and digital integration are making high-end products that boost margins and competitive positioning.
.webp "Top Country Growth Comparison Absorbable Pga Surgical Sutures Market Cagr (2026 2036)")
| Country | CAGR |
|---|---|
| China | 8.9% |
| India | 8.3% |
| Germany | 7.6% |
| Brazil | 6.9% |
| USA | 6.3% |
| UK | 5.6% |
| Japan | 5% |
Source: FMI analysis based on primary research and proprietary forecasting model
From 2026 to 2036, the global market for absorbable pga surgical sutures is expected to grow at a CAGR of 6.6%. The study looks at more than 30 countries, and the main markets are listed below.
The United States is expected to grow at a rate of 6.3% per year until 2036. This is because there is already a lot of demand from the main application sectors and ongoing investments in capacity.
United Kingdom is projected to grow at a CAGR of 5.6% through 2036, shaped by established demand from primary application sectors and ongoing capacity investment.
Germany is projected to grow at a CAGR of 7.6% through 2036, shaped by established demand from primary application sectors and ongoing capacity investment.
Japan is projected to grow at a CAGR of 5.0% through 2036, shaped by established demand from primary application sectors and ongoing capacity investment.
China is projected to grow at a CAGR of 8.9% through 2036, shaped by established demand from primary application sectors and ongoing capacity investment.
India is projected to grow at a CAGR of 8.3% through 2036, shaped by established demand from primary application sectors and ongoing capacity investment.
Competition among well-known companies is what makes the absorbable pga surgical sutures market what it is. Johnson & Johnson stays on top by having a wide range of products and a strong distribution network.
Ethicon LLC and Medtronic compete with each other by focusing on specific products and areas of expertise.
Companies that are just starting out grow by offering low prices and focusing on niche applications.
Key global companies leading the absorbable pga surgical sutures market include:
| Company | Product Range | Regulatory Compliance | Market Access | Innovation |
|---|---|---|---|---|
| Johnson & Johnson | High | Strong | Strong | High |
| Ethicon LLC | High | Strong | Strong | High |
| Medtronic | High | Strong | Medium | Medium |
| B. Braun | Medium | Medium | Medium | Medium |
| Peters Surgical | Medium | Medium | Medium | Medium |
| DemeTech | Medium | Medium | Medium | Medium |
Source: Future Market Insights competitive analysis, 2026.
Key Developments in Absorbable PGA Surgical Sutures Market
Major Global Players:
Emerging Players/Startups
| Metric | Value |
|---|---|
| Quantitative Units | USD 348.3 million to USD 659.9 million, at a CAGR of 6.6% |
| Market Definition | The absorbable PGA surgical sutures market encompasses synthetic absorbable sutures manufactured from polyglycolic acid polymer in monofilament, braided, coated, and non-coated configurations for wound closure in general surgery, obstetrics, urology, cardiovascular, and orthopedic applications. |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa |
| Countries Covered | India, China, USA, UK, Germany, Japan, and 30+ countries |
| Key Companies Profiled | Johnson & Johnson, Ethicon LLC, Medtronic, B. Braun, Peters Surgical |
| Forecast Period | 2026 to 2036 |
| Approach | Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions. |
This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.
How large is the demand for Absorbable PGA Surgical Sutures in the global market in 2026?
Demand for absorbable PGA surgical sutures in the global market is estimated to be valued at USD 348.26 million in 2026, supported by steady procurement across general surgery, gynaecology, gastrointestinal procedures, and soft tissue approximation in hospital and ambulatory surgical centre settings.
What will be the market size of Absorbable PGA Surgical Sutures by 2036?
Market size for absorbable PGA surgical sutures is projected to reach USD 659.90 million by 2036, driven by rising global surgical procedure volumes, expanding healthcare access in emerging markets, and continued preference for absorbable sutures in soft tissue closure.
What is the expected demand growth for Absorbable PGA Surgical Sutures between 2026 and 2036?
The market is expected to grow at a CAGR of 6.6% between 2026 and 2036, reflecting sustained surgical procedure volume growth, broadening absorbable suture adoption across surgical specialties, and continued replacement of non-absorbable alternatives in soft tissue applications.
Which Type is poised to lead global sales by 2026?
Monofilament accounts for 67.0% in 2026, reflecting surgeon preference for smooth tissue passage, reduced bacterial adherence, and predictable knot performance in general surgery, gastrointestinal, and soft tissue approximation procedures.
Which Application holds the largest share of the market?
General Surgery represents 45.0% of the market in 2026, supported by the high volume of abdominal, gastrointestinal, and soft tissue procedures performed in hospital and ambulatory settings where absorbable PGA sutures are the default choice for internal closure.
What is driving demand in China?
China registers a CAGR of 8.9% through 2036, propelled by healthcare infrastructure expansion, rising surgical procedure volumes, growing hospital capacity, and expanding domestic manufacturing of absorbable suture products.
What does the absorbable PGA surgical sutures market definition mean in this report?
The absorbable PGA surgical sutures market encompasses synthetic absorbable sutures manufactured from polyglycolic acid polymer in monofilament, braided, coated, and non-coated configurations used for soft tissue approximation and ligation across general surgery, obstetrics and gynaecology, gastrointestinal, and other surgical specialties.
How does FMI build and validate the Absorbable PGA Surgical Sutures forecast?
Forecasting models apply a hybrid bottom-up methodology with verified data cross-validated against industry statistics, including surgical procedure volume records, hospital consumables purchasing data, and suture manufacturer shipment disclosures.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Absorbable PGA Surgical Sutures Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
